Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
about
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Phase I feasibility study for ...... reast carcinomatous meningitis
@en
type
label
Phase I feasibility study for ...... reast carcinomatous meningitis
@en
prefLabel
Phase I feasibility study for ...... reast carcinomatous meningitis
@en
P2093
P50
P1476
Phase I feasibility study for ...... reast carcinomatous meningitis
@en
P2093
Christophe Passot
Claire Bonneau
Emmanuelle Mouret-Fourme
Fawzia Mefti
Gilles Paintaud
Isabelle Turbiez
Jacques Li
Maya Gutierrez
Sophie Taillibert
Véronique Dieras
P356
10.1016/J.EJCA.2018.02.032
P577
2018-04-07T00:00:00Z